Tag: Heart Failure
Left Ventricular Assist Device Ups QoL in Ambulatory Heart Failure
Left ventricular assist devices increase quality-adjusted life-years, readmissions, and costs
β-Blockers Linked to Reduced Mortality in HFrEF, A-Fib
Reduction in all-cause mortality, but not hospitalization, regardless of pattern, burden of a-fib
Metformin Tied to Better Clinical Outcomes in CKD, CHF, CLD
Reduced all-cause death for chronic kidney disease, congestive heart failure, chronic liver disease
Weight Gain Worsens Post-Discharge Prognosis in Acute HF
Increased odds of 30-day mortality or heart failure readmission with each kg increase in weight
Phase I Trial Shows Promise for Cimaglermin in Heart Failure
First-in-human trial shows cimaglermin generally well tolerated in left ventricular systolic dysfunction
Review Links Natriuretic Peptide Thresholds to Mortality in ADHF
Achieving NP predischarge thresholds cuts mortality, readmission in acute decompensated heart failure
Three Factors Weigh Heavy in Risk of Heart Failure
Prevention of obesity, HTN, diabetes could substantially cut public health impact of heart failure
AHA: Wide Variation in Prices of Generic Heart Failure Meds
Patients can spend from $12 to $400 a month to fill prescriptions
AHA: Interatrial Shunt Effective at One Year in Heart Failure
Findings for patients with heart failure with preserved left ventricular ejection fraction
AHA: Hospitalizations Up for Heart Failure in the United States
But length of stay and mortality are decreasing
